Tevogen Inc. SEC filings TVGNW
Tevogen Inc. has 309 filings in SEC EDGAR's recent list, going back to Jun 10, 2021. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Nov 4, 2026 | — |
| 4 | Insider transaction | Nov 4, 2026 | Nov 2, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Sep 16, 2026 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Sep 16, 2026 | — |
| 4 | Insider transaction | Sep 16, 2026 | Sep 14, 2026 |
| 4 | Insider transaction | Sep 16, 2026 | Sep 14, 2026 |
| 4 | Insider transaction | Sep 15, 2026 | Sep 11, 2026 |
| 4 | Insider transaction | Sep 15, 2026 | Sep 11, 2026 |
| 4 | Insider transaction | Sep 15, 2026 | Sep 11, 2026 |
| 4 | Insider transaction | Sep 15, 2026 | Sep 11, 2026 |
| 4 | Insider transaction | Sep 15, 2026 | Sep 11, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jul 14, 2026 | — |
| 4 | Insider transaction | Jul 10, 2026 | Jul 10, 2026 |
| 4 | Insider transaction | Jul 10, 2026 | Jul 10, 2026 |
| 4 | Insider transaction | Jul 10, 2026 | Jul 10, 2026 |
| 4 | Insider transaction | Jul 10, 2026 | Jul 10, 2026 |
| 4 | Insider transaction | Jul 10, 2026 | Jul 10, 2026 |
| 4 | Insider transaction | Jul 10, 2026 | Jul 10, 2026 |
| 4 | Insider transaction | Jul 10, 2026 | Jul 10, 2026 |
| 4 | Insider transaction | Mar 17, 2026 | Mar 10, 2026 |
| 144 | Notice of proposed sale | Feb 6, 2026 | — |
| 144 | Notice of proposed sale | Dec 30, 2025 | — |
| 4 | Insider transaction | Dec 22, 2025 | Dec 18, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Dec 16, 2025 | — |
| 4 | Insider transaction | Dec 15, 2025 | Dec 11, 2025 |
| 4 | Insider transaction | Dec 12, 2025 | Dec 11, 2025 |
| 4 | Insider transaction | Aug 18, 2025 | Aug 15, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jul 25, 2025 | — |
| 4 | Insider transaction | Jul 1, 2025 | Jun 27, 2025 |
| 4 | Insider transaction | Jul 1, 2025 | Jun 27, 2025 |
| 4 | Insider transaction | Jul 1, 2025 | Jun 27, 2025 |
| 4 | Insider transaction | Jul 1, 2025 | Jun 27, 2025 |
| 4 | Insider transaction | Jun 9, 2025 | Jun 9, 2025 |
| 144 | Notice of proposed sale | Jun 9, 2025 | — |
| 4 | Insider transaction | Mar 14, 2025 | Mar 12, 2025 |
| 4 | Insider transaction | Mar 11, 2025 | Mar 7, 2025 |
| 4 | Insider transaction | Mar 6, 2025 | Mar 4, 2025 |
| 4 | Insider transaction | Dec 26, 2024 | Dec 23, 2024 |
| 4 | Insider transaction | Dec 26, 2024 | Dec 23, 2024 |
| 4 | Insider transaction | Dec 26, 2024 | Dec 23, 2024 |
| 4 | Insider transaction | Dec 26, 2024 | Dec 23, 2024 |
| 4 | Insider transaction | Dec 26, 2024 | Dec 23, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 12, 2024 | — |
| 4 | Insider transaction | Oct 18, 2024 | Oct 17, 2024 |
| 4 | Insider transaction | Jun 13, 2024 | Jun 12, 2024 |
| 4 | Insider transaction | Jun 7, 2024 | Jun 5, 2024 |
| SC 13G | Ownership over 5% (passive) | Mar 4, 2024 | — |
| SC 13D | Ownership over 5% (active) | Feb 22, 2024 | — |
| SC 13D | Ownership over 5% (active) | Feb 22, 2024 | — |
| 4 | Insider transaction | Feb 16, 2024 | Feb 14, 2024 |
| 4 | Insider transaction | Feb 16, 2024 | Feb 14, 2024 |
| 4 | Insider transaction | Feb 16, 2024 | Feb 14, 2024 |
| 4 | Insider transaction | Feb 16, 2024 | Feb 14, 2024 |
| 4 | Insider transaction | Feb 16, 2024 | Feb 14, 2024 |
| 4 | Insider transaction | Feb 16, 2024 | Feb 14, 2024 |
| 4 | Insider transaction | Feb 16, 2024 | Feb 14, 2024 |
| 4 | Insider transaction | Feb 16, 2024 | Feb 14, 2024 |
| 4 | Insider transaction | Feb 16, 2024 | Feb 14, 2024 |
| 3 | Initial insider ownership | Feb 16, 2024 | Feb 14, 2024 |
| 3 | Initial insider ownership | Feb 16, 2024 | Feb 14, 2024 |
| 3 | Initial insider ownership | Feb 16, 2024 | Feb 14, 2024 |
| 3 | Initial insider ownership | Feb 16, 2024 | Feb 14, 2024 |
| 3 | Initial insider ownership | Feb 16, 2024 | Feb 14, 2024 |
| 3 | Initial insider ownership | Feb 16, 2024 | Feb 14, 2024 |
| 3 | Initial insider ownership | Feb 16, 2024 | Feb 14, 2024 |
| 3 | Initial insider ownership | Feb 16, 2024 | Feb 14, 2024 |
| 3 | Initial insider ownership | Feb 16, 2024 | Feb 14, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 12, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 8, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Jan 22, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Jul 27, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jul 20, 2023 | — |
| 4 | Insider transaction | Jul 18, 2023 | Jul 17, 2023 |
| SC 13D | Ownership over 5% (active) | Jul 7, 2023 | — |
| 4/A | Primary document | Jun 21, 2023 | Jun 7, 2023 |
| 3/A | Primary document | Jun 21, 2023 | Jun 7, 2023 |
| 3 | Initial insider ownership | Jun 14, 2023 | Jun 7, 2023 |
| 3 | Initial insider ownership | Jun 14, 2023 | Jun 7, 2023 |
| 3 | Initial insider ownership | Jun 14, 2023 | Jun 7, 2023 |
| 3/A | Primary document | Jun 14, 2023 | Jun 7, 2023 |
| 3 | Initial insider ownership | Jun 14, 2023 | Jun 7, 2023 |
| 3 | Initial insider ownership | Jun 14, 2023 | Jun 7, 2023 |
| 3 | Initial insider ownership | Jun 14, 2023 | Jun 7, 2023 |
| 3 | Initial insider ownership | Jun 13, 2023 | Jun 7, 2023 |
| 4 | Insider transaction | Jun 12, 2023 | Jun 7, 2023 |
| SC 13D/A | Amended ownership over 5% (active) | Jun 8, 2023 | — |
| 4 | Insider transaction | Jun 8, 2023 | Jun 7, 2023 |
| 3 | Initial insider ownership | Feb 16, 2023 | Feb 3, 2023 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2023 | — |
| SC 13G | Ownership over 5% (passive) | Feb 13, 2023 | — |
| SC 13D/A | Amended ownership over 5% (active) | Feb 13, 2023 | — |
| 4 | Insider transaction | Feb 1, 2023 | Jan 30, 2023 |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2022 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2022 | — |
| SC 13G | Ownership over 5% (passive) | Feb 8, 2022 | — |
| SC 13D | Ownership over 5% (active) | Nov 15, 2021 | — |
| SC 13G | Ownership over 5% (passive) | Nov 12, 2021 | — |
| 4 | Insider transaction | Nov 8, 2021 | Nov 8, 2021 |
| 3 | Initial insider ownership | Nov 3, 2021 | Nov 3, 2021 |
| 3 | Initial insider ownership | Nov 3, 2021 | Nov 3, 2021 |
| 3 | Initial insider ownership | Nov 3, 2021 | Nov 3, 2021 |
| 3 | Initial insider ownership | Nov 3, 2021 | Nov 3, 2021 |
| 3 | Initial insider ownership | Nov 3, 2021 | Nov 3, 2021 |
| 3 | Initial insider ownership | Nov 3, 2021 | Nov 3, 2021 |
| 3 | Initial insider ownership | Nov 3, 2021 | Nov 3, 2021 |
| 3 | Initial insider ownership | Nov 3, 2021 | Nov 3, 2021 |
| 3 | Initial insider ownership | Nov 3, 2021 | Nov 3, 2021 |
Showing 111 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- TVGN (Nasdaq), TVGNW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Warren, NJ
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1860871
- Former names
- Tevogen Bio Holdings Inc. (until Jul 30, 2026); Semper Paratus Acquisition Corp (until Feb 15, 2024)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.